Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Agomelatine versus sertraline for bipolar I depression
IRCT20200803048284N1Phase 3Completed
- Sponsor
- Kashan University of Medical Sciences
- Start
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of agomelatine and sertraline in bipolar I disorder (2 arms), sponsored by Kashan University of Medical Sciences. Primary endpoint: Change in Hamilton depression score. Started Sep 2020; status: completed.
02
Drugs
agomelatinesertraline
03
Conditions
bipolar I disorder
Beyond the preview
Go deeper on IRCT20200803048284N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200803048284N1.